Evidence map›Paper›PMID 39695590›Full record

ArticleBMC complementary medicine and therapies2024

BABINE: An original and user-friendly scale for the simple and quick management of herb-drug interactions in clinical practice.

Anthony Cnudde, Camille Allely, Natacha Biset, Pierre Champy, Nathalie Fouilhé, Fanny Huret, Sibi Lawson, Aline Mercan, Doris Pascale Noukela Noumi, Serge Michalet and 8 more

Abstract read
In one paragraph

Article in BMC complementary medicine and therapies, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

18 authors.

Anthony CnuddeDepartment of Pharmacotherapy and Pharmaceutics, Faculty of Pharmacy, Université libre de Bruxelles (ULB), Brussels, Belgium. anthony.cnudde@ulb.be.
Camille AllelyCNHIM, Theriaque, France.
Natacha BisetDepartment of Pharmacotherapy and Pharmaceutics, Faculty of Pharmacy, Université libre de Bruxelles (ULB), Brussels, Belgium.
Pierre ChampyÉquipe Chimie des Substances Naturelles, BioCIS, CNRS, Université Paris-Saclay, Orsay, France.
Nathalie FouilhéCentre Hospitalier Universitaire Grenoble Alpes, Grenoble, France.
Fanny HuretNutrition Risk Assessment Unit, French Agency for Food, Environmental and Occupational, Health & Safety (ANSES), Maisons-Alfort, France.
Sibi LawsonUniversité Libre de Bruxelles, Brussels, Belgium.
Aline MercanHospices Civils de Lyon, and LBBE, Hôpital de la Croix-Rousse, Université Claude Bernard Lyon 1, Lyon, France.
Doris Pascale Noukela NoumiUniversité Libre de Bruxelles, Brussels, Belgium.
Serge MichaletPharmacognosy, Department of Drug Sciences, Institut des Sciences Pharmaceutiques et Biologiques (ISPB), UMR 5557 Ecologie Microbienne, Université Claude Bernard Lyon 1, Lyon, France.
Andrea MontisRD3 Unit of Pharmacognosy, Bioanalysis and Drug Discovery, Faculty of Pharmacy, Université Libre de Bruxelles, Campus Plaine, Brussels, 1050, Belgium.
Stephanie PochetDepartment of Pharmacotherapy and Pharmaceutics, Faculty of Pharmacy, Université libre de Bruxelles (ULB), Brussels, Belgium.
Audrey SchilsDepartment of Pharmacotherapy and Pharmaceutics, Faculty of Pharmacy, Université libre de Bruxelles (ULB), Brussels, Belgium.
Cecilia TangetenRD3 Unit of Pharmacognosy, Bioanalysis and Drug Discovery, Faculty of Pharmacy, Université Libre de Bruxelles, Campus Plaine, Brussels, 1050, Belgium.
Michel TodHospices Civils de Lyon, and LBBE, Hôpital de la Croix-Rousse, Université Claude Bernard Lyon 1, Lyon, France.
Pierre Van AntwerpenRD3 Unit of Pharmacognosy, Bioanalysis and Drug Discovery, Faculty of Pharmacy, Université Libre de Bruxelles, Campus Plaine, Brussels, 1050, Belgium.
Audrey VervackeHôpital universitaire de Bruxelles - site Erasme (HUB) BE, Brussels, Belgium.
Florence SouardDepartment of Pharmacotherapy and Pharmaceutics, Faculty of Pharmacy, Université libre de Bruxelles (ULB), Brussels, Belgium.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundWhile more and more people tend to use herbal products thinking they are safer than conventional western medicine, the reality is other. If natural products are bio-active and possess potential therapeutic activities, then the benefit/risk balance should be considered like any other health product. Some herbs are known to have the potential to interact with patient's treatment and to cause adverse drug reactions. While these are scarce, they are potentially harmful, and can lead to major sequels and even death in some cases. Despite these known facts, little guidelines about how to evaluate the risk of interaction and to handle them exist in literature. Notably, few scales allowing to assess the risk of a specific combination of herbs and drugs exist.

methodWe propose a new scoring method BABINE (Boosting Analysis of Bibliography for herb- drug INteraction Evaluation) and discuss a scale to evaluate this risk based on iterative rounds of experts' discussion.

resultsAfter 6 rounds of case reports/clinical studies evaluation, we analyzed and synthesized criteria identified as important by the experts and developed a corresponding evaluation scale.

conclusionEven if our scale greatly simplifies pharmacological events, we believe it provides a robust and transparent way to rapidly assess the risk of adverse event.

Indexed as

Herb-Drug InteractionsHumansRisk AssessmentAdverse eventBabineDecision supportDelphiHerbal supplemenHer-drug interactionsPharmacovigilancePhytotherapyPhytovigilanceRisk

Identifiers

PMID39695590
PMCPMC11654206

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.